Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1636 1639 1644 1675 1682 1684
This examiner grants 64% of resolved cases
Jeremy C. Flinders operates in Art Unit 1636 within Tech Center 1600, where he has handled 609 resolved cases. His overall allowance rate is 63.5 percent. The median duration for an application to reach allowance under his review is 1382 days. These figures establish the expectations for pendency and success for applicants assigned to his docket. The 609 resolved cases provide a basis for understanding the typical prosecution path in this art unit.
Practitioners may find value in direct communication, as the interview lift is 16.7 percent. This figure suggests that engaging in an interview correlates with the likelihood of securing a patent grant. Given the median of 1382 days to allowance, an interview could be a tool to address examiner concerns and move toward a final resolution. The data indicates that the 16.7 percent interview lift is a measurable component of the prosecution process.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19463001 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | Final Rejection | Natera, Inc. |
| 19463003 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | Final Rejection | Natera, Inc. |
| 17695073 | STRUCTURED SUBSTRATES FOR OPTICAL SURFACE PROFILING | Non-Final OA | TRUSTEES OF BOSTON UNIVERSITY |
| 18580283 | ITERATIVE OLIGONUCLEOTIDE BARCODE EXPANSION FOR LABELING AND LOCALIZING MANY BIOMOLECULES | Non-Final OA | GOOGLE LLC |
| 18387669 | SYSTEMS AND METHODS FOR METABOLOME ANALYSIS | Non-Final OA | 10x Genomics, Inc. |
| 18334775 | METHODS OF DETERMINING A SURGICAL MARGIN AND METHODS OF USE THEREOF | Non-Final OA | 10x Genomics, Inc. |
| 18162118 | Oligonucleotide Paints | Non-Final OA | President and Fellows of Harvard College |
| 18560003 | STRUCTURE BASED ISOLATION OF PMHC-RESTRICTED ANTIBODIES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18063162 | MULTIPLEXED DETECTION WITH ISOTOPE-CODED REPORTERS | Non-Final OA | Massachusetts Institute of Technology |
| 17684289 | METHODS AND COMPOSITIONS FOR WHOLE TRANSCRIPTOME AMPLIFICATION | Non-Final OA | Becton, Dickinson and Company |
| 17933051 | METHODS OF ASSAYING PROTEINS | Non-Final OA | NAUTILUS SUBSIDIARY, INC. |
| 18578558 | COMPOSITIONS, METHODS, AND SYSTEMS FOR ENHANCED DNA TRANSFORMATION IN BACTERIA | Non-Final OA | North Carolina State University |
| 18323356 | MULTIPLEX DETECTION OF INTRACELLULAR OR SURFACE MOLECULAR TARGETS IN SINGLE CELLS | Non-Final OA | Yale University |
| 17764804 | DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING | Final Rejection | Yale University |
| 18304993 | REVERSE TRANSCRIPTION OF POLYNUCLEOTIDES COMPRISING UNNATURAL NUCLEOTIDES | Final Rejection | The Scripps Research Institute |
| 18176062 | CRISPR/Cas9 MULTIPLEX KNOCKOUT OF HOST CELL PROTEINS | Final Rejection | HOFFMANN-LA ROCHE INC. |
| 17878458 | SYSTEM, ASSAY AND METHOD FOR PARTITIONING PROTEINS | Non-Final OA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 18342294 | DNA Based Bar Code for Improved Food Traceability | Non-Final OA | Lawrence Livermore National Security, LLC |
| 18173551 | BIOMARKERS OF IMMUNE DYSFUNCTION IN RESPONSE TO CHRONIC STRESS, METHODS OF USE AND DIAGNOSTIC KITS | Non-Final OA | The Government of the United States, as Represented by the Secretary of the Army |
| 17864655 | PRE-TEMPLATED INSTANT PARTITIONING OF DNA-ENCODED LIBRARIES | Non-Final OA | ILLUMINA, INC. |
| 17758048 | Method For Constructing Gene Mutation Library | Non-Final OA | Nanjing GenScript Biotech Co., Ltd. |
| 18191792 | COMPOSITIONS AND METHODS FOR DETECTING RARE SEQUENCE VARIANTS | Non-Final OA | AccuraGen Holdings Limited |
| 17715890 | LIBRARIES FOR MUTATIONAL ANALYSIS | Final Rejection | Twist Bioscience Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy